Fig. 2

The relationship between panel-TMB and the tumor mutation burden estimated by whole-exome sequencing (wTMB) in the TCGA dataset. a The distribution of NsMs was obtained by whole-exome sequencing (upper panel) and a 69-gene panel (lower panel) for 37 DLBCL patients. b panel-TMB and wTMB demonstrated a significant positive correlation in 37 DLBCL patients. R, Spearman correlation coefficient